162 related articles for article (PubMed ID: 2130925)
21. Unusual A alpha 16Arg-->Cys dysfibrinogenaemic family: absence of normal A alpha-chains in fibrinogen from two of four heterozygous siblings.
Galanakis D; Spitzer S; Scharrer I
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):67-71. PubMed ID: 8457654
[TBL] [Abstract][Full Text] [Related]
22. Fibrinogen Sapporo: dysfibrinogenemia characterized by the replacement of A alpha arginine-16 by histidine resulting in the delayed release of fibrinopeptide A by thrombin.
Asakura S; Terukina S; Yamazumi K; Matsuda M; Murayama H; Higuchi A; Musashi M; Sakurada K; Miyazaki T
Nihon Ketsueki Gakkai Zasshi; 1989 Sep; 52(6):1094-104. PubMed ID: 2588959
[TBL] [Abstract][Full Text] [Related]
23. Fibrinogen Milano. VI: A heterozygous dysfibrinogenemia (A alpha 16 Arg----His) with bleeding tendency.
Bögli C; Cofrancesco E; Cortellaro M; Della Volpe A; Hofer A; Furlan M; Zanussi C
Eur J Haematol; 1990 Jul; 45(1):26-30. PubMed ID: 2379562
[TBL] [Abstract][Full Text] [Related]
24. Fibrinogen Ledyard (A alpha Arg16----Cys): biochemical and physiologic characterization.
Lee MH; Kaczmarek E; Chin DT; Oda A; McIntosh S; Bauer KA; Clyne LP; McDonagh J
Blood; 1991 Oct; 78(7):1744-52. PubMed ID: 1912564
[TBL] [Abstract][Full Text] [Related]
25. Abnormal polymerization and normal binding of plasminogen and t-PA in three new dysfibrinogenaemias: Barcelona III and IV (gamma Arg 275-->His) and Villajoyosa (gamma Arg 275-->Cys).
Borrell M; Garí M; Coll I; Vallvé C; Tirado I; Soria JM; Sala N; Muñoz C; Oliver A; García A
Blood Coagul Fibrinolysis; 1995 May; 6(3):198-206. PubMed ID: 7654933
[TBL] [Abstract][Full Text] [Related]
26. Delayed release of an abnormal fibrinopeptide A from fibrinogen Manchester: effect of the A alpha 16 Arg leads to His substitution upon fibrin monomer polymerization and the immunological crossreactivity of the peptide.
Lane DA; Southan C; Ireland H; Thompson E; Kehl M; Henschen A
Br J Haematol; 1983 Apr; 53(4):587-97. PubMed ID: 6830702
[TBL] [Abstract][Full Text] [Related]
27. Direct analysis of plasma fibrinogen-derived fibrinopeptides by high performance liquid chromatography: investigation of A alpha-chain N-terminal heterogeneity.
Southan C; Thompson E; Lane DA
Thromb Haemost; 1986 Oct; 56(2):193-7. PubMed ID: 3643663
[TBL] [Abstract][Full Text] [Related]
28. Electrospray ionisation mass spectrometry facilitates detection of fibrinogen (Bbeta 14 Arg --> Cys) mutation in a family with thrombosis.
Brennan SO; Hammonds B; Spearing R; George PM
Thromb Haemost; 1997 Dec; 78(6):1484-7. PubMed ID: 9423799
[TBL] [Abstract][Full Text] [Related]
29. A novel fibrinogen variant--Liberec: dysfibrinogenaemia associated with gamma Tyr262Cys substitution.
Kotlín R; Sobotková A; Suttnar J; Salaj P; Walterová L; Riedel T; Reicheltová Z; Dyr JE
Eur J Haematol; 2008 Aug; 81(2):123-9. PubMed ID: 18485115
[TBL] [Abstract][Full Text] [Related]
30. Fibrinogen New Britain: characterization of an A alpha Arg 16-->His variant human fibrinogen.
Webb CD; Hantgan RR; Byeff PD; Owen J
Blood Coagul Fibrinolysis; 1994 Apr; 5(2):233-8. PubMed ID: 8054455
[TBL] [Abstract][Full Text] [Related]
31. Novel structure elucidation strategy for genetically abnormal fibrinogens with incomplete fibrinopeptide release as applied to fibrinogen Schwarzach.
Henschen A; Kehl M; Deutsch E
Hoppe Seylers Z Physiol Chem; 1983 Dec; 364(12):1747-51. PubMed ID: 6667926
[TBL] [Abstract][Full Text] [Related]
32. A frameshift mutation in the human fibrinogen Aalpha-chain gene (Aalpha(499)Ala frameshift stop) leading to dysfibrinogen San Giovanni Rotondo.
Margaglione M; Vecchione G; Santacroce R; D'Angelo F; Casetta B; Papa ML; Grandone E; Di Minno G
Thromb Haemost; 2001 Dec; 86(6):1483-8. PubMed ID: 11776317
[TBL] [Abstract][Full Text] [Related]
33. Direct analysis of plasma fibrinogen-derived fibrinopeptides by high-performance liquid chromatography: investigation of nine congenital fibrinogen abnormalities.
Southan C; Thompson E; Lane DA
Br J Haematol; 1987 Apr; 65(4):469-73. PubMed ID: 3580304
[TBL] [Abstract][Full Text] [Related]
34. Fibrinogen Caracas V, an abnormal fibrinogen with an Aalpha 532 Ser-->Cys substitution associated with thrombosis.
Marchi R; Lundberg U; Grimbergen J; Koopman J; Torres A; de Bosch NB; Haverkate F; Arocha Piñango CL
Thromb Haemost; 2000 Aug; 84(2):263-70. PubMed ID: 10959699
[TBL] [Abstract][Full Text] [Related]
35. [Analysis of abnormal fibrinogens--introduction of new strategies].
Matsuda M; Yoshida N; Terukina S; Yamazumi K; Asakura S; Maekawa H
Rinsho Byori; 1989 Apr; Spec No 81():55-63. PubMed ID: 2754812
[No Abstract] [Full Text] [Related]
36. Substitution of tyrosine for phenylalanine in fibrinopeptide A results in preferential thrombin cleavage of fibrinopeptide B from fibrinogen.
Rooney MM; Mullin JL; Lord ST
Biochemistry; 1998 Sep; 37(39):13704-9. PubMed ID: 9753458
[TBL] [Abstract][Full Text] [Related]
37. Fibrinogen Milano XIII (Aalpha 19 Arg-->Gly): a dysfunctional variant with an amino acid substitution in the N-terminal polymerization site.
Bolliger-Stucki B; Bucciarelli P; Lämmle B; Furlan M
Thromb Res; 1999 Dec; 96(5):399-405. PubMed ID: 10605955
[No Abstract] [Full Text] [Related]
38. Fibrinogen Nový Jicín and Praha II: cases of hereditary Aalpha 16 Arg-->Cys and Aalpha 16 Arg-->His dysfibrinogenemia.
Kotlín R; Chytilová M; Suttnar J; Riedel T; Salaj P; Blatný J; Santrůcek J; Klener P; Dyr JE
Thromb Res; 2007; 121(1):75-84. PubMed ID: 17408725
[TBL] [Abstract][Full Text] [Related]
39. Fibrinogen Poissy II (gammaN361K): a novel dysfibrinogenemia associated with defective polymerization and peptide B release.
Mathonnet F; Guillon L; Detruit H; Mazmanian GM; Dreyfus M; Alvarez JC; Giudicelli Y; de Mazancourt P
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):293-8. PubMed ID: 12695754
[TBL] [Abstract][Full Text] [Related]
40. Fibrinogen Manchester: identification of an abnormal fibrinopeptide A with a C-terminal arginine leads to histidine substitution.
Southan C; Kehl M; Henschen A; Lane DA
Br J Haematol; 1983 May; 54(1):143-51. PubMed ID: 6849832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
